| 标题 |
Neratinib + fulvestrant + trastuzumab for HR-positive, HER2-negative, HER2-mutant metastatic breast cancer: outcomes and biomarker analysis from the SUMMIT trial |
| 网址 | |
| DOI | |
| 其它 |
期刊:Annals of Oncology 作者:Komal Jhaveri; L.D. Eli; Hans Wildiers; Sara A. Hurvitz; Ángel Guerrero‐Zotano; et al 出版日期:2023-08-18 |
| 求助人 | |
| 下载 | 该求助完结已超 24 小时,文件已从服务器自动删除,无法下载。 |
PDF的下载单位、IP信息已删除
(2025-6-4)